International Biotechnology Trust’s BeOne Medicines Ltd ONC Stock Holding History

International Biotechnology Trust’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.28M	Buy	12,700 +4,000	+46%	+$791K	0.77%	37
2023 Q2	$1.55M	Sell	8,700 -14,000	-62%	-$3.22M	0.47%	41
2023 Q1	$4.89M	Buy	22,700 +7,000	+45%	+$1.68M	1.37%	25
2022 Q4	$3.45M	Hold	15,700	–	–	1.07%	29
2022 Q3	$2.12M	Buy	15,700 +13,158	+518%	+$2.26M	0.68%	42
2022 Q2	$15.7K	Sell	2,542 -13,158	-84%	-$2.06M	0.16%	70
2022 Q1	$11.4M	Sell	15,700 -4,300	-22%	-$914K	2.57%	14
2021 Q4	$5.4M	Buy	+20,000	New	+$6.75M	1.2%	28
2020 Q1	–	Sell	-14,000	Closed	-$2.32M	–	65
2019 Q4	$2.32M	Buy	+14,000	New	+$2.33M	0.84%	29
2018 Q2	–	Sell	-9,500	Closed	-$1.6M	–	62
2018 Q1	$1.6M	Hold	9,500	–	–	0.62%	36
2017 Q4	$928K	Buy	+9,500	New	+$870K	0.33%	55
2017 Q2	–	Sell	-66,041	Closed	-$2.42M	–	66
2017 Q1	$2.42M	Buy	+66,041	New	+$2.41M	0.93%	29

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

International Biotechnology Trust's ONC Position: Q3 2023 in Review

International Biotechnology Trust increased its BeOne Medicines Ltd (ONC) stake by 46% in Q3 2023, buying an estimated $791K and bringing the position to 12,700 shares worth $2.28M. The position accounts for 0.77% of the portfolio, ranked #37.

International Biotechnology Trust first reported a position in ONC in Q1 2017 and has held it in 12 quarters since. The position peaked at $11.4M in Q1 2022. 201 funds tracked by Wall St. Rank hold ONC as of Q3 2023.

International Biotechnology Trust held 12,700 shares of BeOne Medicines Ltd worth $2.28M as of Q3 2023.
International Biotechnology Trust bought 4,000 BeOne Medicines Ltd shares in Q3 2023, an estimated $791K.
BeOne Medicines Ltd made up 0.77% of International Biotechnology Trust's portfolio in Q3 2023, its #37 holding.
International Biotechnology Trust first reported a position in BeOne Medicines Ltd in Q1 2017 and has held it in 12 quarters since.
International Biotechnology Trust's BeOne Medicines Ltd position peaked at $11.4M in Q1 2022.
201 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.